Schene, M. R. http://orcid.org/0000-0002-9273-6271
Willems, H. C. http://orcid.org/0000-0002-3166-6951
Driessen, J. H. M. http://orcid.org/0000-0002-4503-6408
Vranken, L. http://orcid.org/0000-0002-6925-4397
Heersprink, F. O. Lambers http://orcid.org/0000-0002-1962-4011
Janzing, H. M. J. http://orcid.org/0000-0002-0195-5840
van der Velde, R. Y. http://orcid.org/0000-0002-3239-2753
van den Bergh, J. P. http://orcid.org/0000-0003-3984-2232
Wyers, C. E. http://orcid.org/0000-0001-7662-3990
Funding for this research was provided by:
Stichting De Weijerhorst
Article History
Received: 1 February 2023
Accepted: 20 December 2023
First Online: 13 February 2024
Declarations
:
: The Weijerhorst Foundation was not involved in conducting the study, analyzing the data, or writing the manuscript.
: This research was approved by the medical ethics board of the Maastricht University Medical Centre (ref. nr. 2022–3319).
: MS, LV, CW, RV, HJ, and JD declare that they have no conflict of interest. JB reports grands for lectures and the position in the advisory board from UCB and Amgen, HW reports a speaker’s fee for lectures from UCB, and FLH reports a speaker’s fee from Amgen, outside the submitted work.